PubRank

Clive G Ballard

Author PubWeight™ 44.46‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Donepezil for the treatment of agitation in Alzheimer's disease. N Engl J Med 2007 4.11
2 Putting brain training to the test. Nature 2010 3.88
3 Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies. J Clin Psychiatry 2008 2.12
4 Depression in Parkinson disease--epidemiology, mechanisms and management. Nat Rev Neurol 2011 1.69
5 Towards defining the neuropathological substrates of vascular dementia. J Neurol Sci 2004 1.63
6 Parkinson disease with dementia: comparing patients with and without Alzheimer pathology. Alzheimer Dis Assoc Disord 2009 1.54
7 Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias. J Am Geriatr Soc 2005 1.31
8 Incidence and prediction of falls in dementia: a prospective study in older people. PLoS One 2009 1.31
9 Endogenous neurogenesis in the human brain following cerebral infarction. Regen Med 2007 1.16
10 Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias. J Clin Psychiatry 2005 1.11
11 Association between mild vascular cognitive impairment and impaired activities of daily living in older stroke survivors without dementia. J Am Geriatr Soc 2005 1.00
12 Dementia with Lewy bodies. Semin Clin Neuropsychiatry 2003 0.94
13 Muscarinic M2 and M4 receptors in anterior cingulate cortex: relation to neuropsychiatric symptoms in dementia with Lewy bodies. Behav Brain Res 2005 0.93
14 Clinical and neuropathological correlates of apolipoprotein E genotype in dementia with Lewy bodies. Dement Geriatr Cogn Disord 2002 0.93
15 NOS3 gene rs1799983 polymorphism and incident dementia in elderly stroke survivors. Neurobiol Aging 2010 0.87
16 Regulation of attention and response to therapy in dementia by butyrylcholinesterase. Pharmacogenetics 2003 0.85
17 Inflammatory mediators in the frontal lobe of patients with mixed and vascular dementia. Dement Geriatr Cogn Disord 2008 0.84
18 Transferrin gene polymorphism in Alzheimer's disease and dementia with Lewy bodies in humans. Neurosci Lett 2002 0.84
19 An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers. Psychopharmacology (Berl) 2008 0.84
20 Subtle attentional deficits in the absence of dementia are associated with an increased risk of post-operative delirium. Dement Geriatr Cogn Disord 2007 0.83
21 Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia. Int J Neuropsychopharmacol 2006 0.83
22 (123I)FP-CIT SPECT in suspected dementia with Lewy bodies: a longitudinal case study. BMJ Open 2013 0.82
23 Increased binding to 5-HT1A and 5-HT2A receptors is associated with large vessel infarction and relative preservation of cognition. Brain 2009 0.81
24 Neurogenic marker abnormalities in the hippocampus in dementia with Lewy bodies. Hippocampus 2010 0.81
25 Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer's disease. J Neurol 2009 0.81
26 Lewy body disease: thalamic cholinergic activity related to dementia and parkinsonism. Neurobiol Aging 2006 0.81
27 Aggressive behavior and neuroleptic medication are associated with increased number of alpha1-adrenoceptors in patients with Alzheimer disease. Am J Geriatr Psychiatry 2007 0.80
28 Genetic associations of autopsy-confirmed vascular dementia subtypes. Dement Geriatr Cogn Disord 2011 0.80
29 Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline. Synapse 2007 0.79
30 Amyloid beta concentrations in older people with Down syndrome and dementia. Neurosci Lett 2008 0.79
31 Cortical serotonin 1A receptor levels are associated with depression in patients with dementia with Lewy bodies and Parkinson's disease dementia. Dement Geriatr Cogn Disord 2008 0.79
32 Choline acetyltransferase activity in vascular dementia and stroke. Dement Geriatr Cogn Disord 2009 0.79
33 Increased neural progenitors in vascular dementia. Neurobiol Aging 2010 0.79
34 Butyrylcholinesterase: impact on symptoms and progression of cognitive impairment. Expert Rev Neurother 2005 0.79
35 Proteasome inhibition leads to early loss of synaptic proteins in neuronal culture. J Neural Transm (Vienna) 2012 0.78
36 An Intron 7 Polymorphism in APP Affects the Age of Onset of Dementia in Down Syndrome. Int J Alzheimers Dis 2010 0.78
37 The extended tau haplotype and the age of onset of dementia in Down syndrome. Dement Geriatr Cogn Disord 2008 0.77
38 Antipsychotic medication is associated with selective alterations in ventricular cerebrospinal fluid Aβ 40 and tau in patients with intractable unipolar depression. Int J Geriatr Psychiatry 2011 0.77
39 Butyrylcholinesterase K variant associated with higher enzyme activity in the temporal cortex of elderly patients. Neurosci Lett 2008 0.77
40 Decreased immunoreactivities of neocortical AMPA receptor subunits correlate with motor disability in Lewy body dementias. J Neural Transm (Vienna) 2013 0.76
41 CSF α-synuclein as a diagnostic biomarker for Parkinson disease and related dementias. Neurology 2010 0.76
42 Biomarkers for dementia diagnosis: differentiating DLB and FTD may be difficult. J Neurol Neurosurg Psychiatry 2012 0.75